S.T.D.
S.T.D. Brand names, S.T.D. Analogs
- Monotetradecylsulfate sodium salt
- Myristyl sulfate, sodium salt
- Niaproof-4
- S.T.D.
- Sodium myristyl sulfate
- Sodium tetradecyl sulfate
- Sodium tetradecyl sulfate 99%
- Tetradecyl sulfate
- Tergitol-4
- Tetradecyl hydrogen sulphate
- Tetradecyl sodium sulfate
- Tetradecyl sulfate, sodium salt
- Tetradecyl sulfuric Acid
- Texapon K 14
S.T.D. Brand Names Mixture
- No information avaliable
S.T.D. Chemical_Formula
C14H30O4S
S.T.D. RX_link
http://www.rxlist.com/cgi/generic2/sotradecol.htm
S.T.D. fda sheet
S.T.D. msds (material safety sheet)
S.T.D. Synthesis Reference
No information avaliable
S.T.D. Molecular Weight
294.452 g/mol
S.T.D. Melting Point
No information avaliable
S.T.D. H2O Solubility
No information avaliable
S.T.D. State
Solid
S.T.D. LogP
No information avaliable
S.T.D. Dosage Forms
Solution for intramuscular injection
S.T.D. Indication
For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.
S.T.D. Pharmacology
Sodium tetradecyl sulfate is an anionic surfactant which occurs as a white, waxy solid. It is used as a sclerosing agent in sclerotherapy. Sclerotherapy is an injection of a sclerosing agent directly through the skin into a lesion and is used primarily for slow-flow vascular anomalies, particularly for venous malformation and lymphatic malformation. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent.
S.T.D. Absorption
No information avaliable
S.T.D. side effects and Toxicity
LD50=1250 mg/kg (Orally in rat); LD50=3 ml/kg (Skin in rat)
S.T.D. Patient Information
No information avaliable
S.T.D. Organisms Affected
Humans and other mammals
